Abbott Laboratories (JOBS) to Stop European Sales of Diet Drug Sold Under the Names Reductil, Reduxade and Zelium in Europe and Meridia in the United States

Published: Jan 22, 2010

Bookmark and Share

Reuters -- Abbott Laboratories (ABT.N) said on Thursday it will suspend European sales of a weight- loss pill in the face of a recommendation by regulators that heart-related risks made the prescription drug too dangerous.

Back to news